Schneider MR - Search Results

1

Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes.

Witzel M, Petersheim D, Fan Y, Bahrami E, Racek T, Rohlfs M, Puchałka J, Mertes C, Gagneur J, Ziegenhain C, Enard W, Stray-Pedersen A, Arkwright PD, Abboud MR, Pazhakh V, Lieschke GJ, Krawitz PM, Dahlhoff M, Schneider MR, Wolf E, Horny HP, Schmidt H, Schäffer AA, Klein C. Witzel M, et al. Among authors: schneider mr. Nat Genet. 2017 May;49(5):742-752. doi: 10.1038/ng.3833. Epub 2017 Apr 3. Nat Genet. 2017. PMID: 28369036 Free PMC article.

2

Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins.

Schneider MR, Lahm H, Wu M, Hoeflich A, Wolf E. Schneider MR, et al. FASEB J. 2000 Apr;14(5):629-40. doi: 10.1096/fasebj.14.5.629. FASEB J. 2000. PMID: 10744620 Review.

3

Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.

Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H. Schneider MR, et al. Cancer Lett. 2000 Apr 3;151(1):31-8. doi: 10.1016/s0304-3835(99)00401-2. Cancer Lett. 2000. PMID: 10766420

4

Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells.

Schneider MR, Zhou R, Hoeflich A, Krebs O, Schmidt J, Mohan S, Wolf E, Lahm H. Schneider MR, et al. Biochem Biophys Res Commun. 2001 Oct 26;288(2):435-42. doi: 10.1006/bbrc.2001.5785. Biochem Biophys Res Commun. 2001. PMID: 11606061

5

IGF-binding protein-5: flexible player in the IGF system and effector on its own.

Schneider MR, Wolf E, Hoeflich A, Lahm H. Schneider MR, et al. J Endocrinol. 2002 Mar;172(3):423-40. doi: 10.1677/joe.0.1720423. J Endocrinol. 2002. PMID: 11874691 Review.

6

Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice.

Zhou R, Flaswinkel H, Schneider MR, Lahm H, Hoeflich A, Wanke R, Wolf E. Zhou R, et al. Among authors: schneider mr. J Mol Endocrinol. 2004 Apr;32(2):349-64. doi: 10.1677/jme.0.0320349. J Mol Endocrinol. 2004. PMID: 15072544

7

Functional consequences of IGFBP excess-lessons from transgenic mice.

Wolf E, Schneider MR, Zhou R, Fisch TM, Herbach N, Dahlhoff M, Wanke R, Hoeflich A. Wolf E, et al. Among authors: schneider mr. Pediatr Nephrol. 2005 Mar;20(3):269-78. doi: 10.1007/s00467-004-1657-z. Epub 2004 Dec 16. Pediatr Nephrol. 2005. PMID: 15602658 Review.

8

Genotyping of transgenic mice: old principles and recent developments.

Schneider MR, Wolf E. Schneider MR, et al. Anal Biochem. 2005 Sep 1;344(1):1-7. doi: 10.1016/j.ab.2005.03.035. Epub 2005 Apr 9. Anal Biochem. 2005. PMID: 16105546 Review. No abstract available.

9

Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology.

Schneider MR, Dahlhoff M, Herbach N, Renner-Mueller I, Dalke C, Puk O, Graw J, Wanke R, Wolf E. Schneider MR, et al. Endocrinology. 2005 Dec;146(12):5237-46. doi: 10.1210/en.2005-0418. Epub 2005 Sep 22. Endocrinology. 2005. PMID: 16179416

10

Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight.

Moerth C, Schneider MR, Renner-Mueller I, Blutke A, Elmlinger MW, Erben RG, Camacho-Hübner C, Hoeflich A, Wolf E. Moerth C, et al. Among authors: schneider mr. Endocrinology. 2007 Jan;148(1):441-51. doi: 10.1210/en.2006-0385. Epub 2006 Sep 28. Endocrinology. 2007. PMID: 17008389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters